Patents by Inventor Bernard Testa

Bernard Testa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-benzylpiperazine compounds
    Patent number: 6686360
    Abstract: The present invention relates to a compound selected from those of formula (I): wherein: R1 represents alkyl, R2 represents hydroxy, alkoxy, or amino, n represents an integer from 1 to 12 inclusive, R3 represents: hydrogen, optionally substituted alkyl, cycloalkyl, pyrimidinyl or optionally substituted phenyl, its isomers, and addition salts thereof with a pharmaceutically acceptable acid or base, medicinal products containing the same are useful in the prevention or treatment of acute and chronic cell ischaemia.
    Type: Grant
    Filed: July 16, 2002
    Date of Patent: February 3, 2004
    Assignee: Les Laboratoires Servier
    Inventors: Serge Labidalle, Jean-Paul Tillement, Bernard Testa, Roméo Cecchelli, Alain Le Ridant, Catherine Harpey, Michael Spedding, Esther Schenker
  • N-benzylpiperazine compounds
    Publication number: 20030158207
    Abstract: The present invention relates to a compound selected from those of formula (I): 1
    Type: Application
    Filed: July 16, 2002
    Publication date: August 21, 2003
    Inventors: Serge Labidalle, Jean-Paul Tillement, Bernard Testa, Romeo Cecchelli, Alain Le Ridant, Catherine Harpey, Michael Spedding, Esther Schenker
  • N-benzylpiperazine compounds
    Patent number: 5849745
    Abstract: A compound of formula (I): ##STR1## In which: R.sub.1 represents linear or branched (C.sub.1 -C.sub.6) alkyl,X represents oxygen or sulfur,R.sub.2 represents optionally substituted alkyl, alkoxy, optionally substituted phenyl, optionally substituted cycloalkyl, 4-(2,3-dithiacyclopent-1-yl)butyl, pyridyl or optionally substituted amino or any one of the groups as defined in the description,R.sub.3 represents hydrogen or cycloalkyl, formyl, optionally substituted phenyl, pyridyl or optionally substituted alkyl,the isomers thereof, the addition salts thereof with a pharmaceutically acceptable acid or base, and medicinal compounds containing them are useful for the treatment of chronic or cellular ischemia.
    Type: Grant
    Filed: December 15, 1997
    Date of Patent: December 15, 1998
    Assignee: ADIR et Compagnie
    Inventors: Michel Wierzbicki, Marie-Fran.cedilla.oise Boussard, Serge Labidalle, Daniel Guyot, Yves Rolland, Jean-Paul Tillement, Bernard Testa, Aime Crevat
  • N-benzylpiperazine compounds
    Patent number: 5492913
    Abstract: The compounds are N-(unsubstituted or substituted) N'-benzylpiperazine compounds and pharmaceutically tolerable salts thereof, useful for treating neuronal disorders resulting from the dysfunctioning of oxidative metabolism.A compound disclosed is: N-ethyl N'-(2-hydroxy-3,4- dimethoxybenzyl)-piperazine and its dihydrochloride.
    Type: Grant
    Filed: March 23, 1994
    Date of Patent: February 20, 1996
    Assignee: Adir et Compagnie
    Inventors: Michel Wierzbicki, Jean Lepagnol, Jean-Paul Tillement, Bernard Testa, Yves Rolland